Related Experiment Video

Updated: Aug 12, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Intrinsic fibrinolytic capacity and systemic inflammation: novel risk factors for arterial thrombotic disease

P M Ridker1

  • 1Cardiovascular Division, Brigham and Womens' Hospital, Harvard Medical School, Boston, Mass. 02115, USA. pmridker@bics.bwh.harvard.edu

Haemostasis
|January 1, 1997
PubMed

Insights

Novel hemostatic and inflammatory markers, including fibrinolysis and C-reactive protein, can better predict arterial thrombotic disease risk than traditional factors. These markers offer new avenues for thrombosis research and cardiovascular disease prevention.

Area of Science:

  • Cardiovascular Medicine
  • Thrombosis Research
  • Inflammation Biology

Background:

  • Traditional cardiovascular risk factors (e.g., hypertension, diabetes) predict less than 50% of arterial thrombotic events.
  • Existing risk stratification models have limitations in identifying all individuals susceptible to cardiovascular disease.

Purpose of the Study:

  • To review the utility of novel hemostatic and thrombotic markers for predicting arterial thrombotic disease risk.
  • To explore the role of systemic micro-inflammation and fibrinolysis in atherogenesis and thrombosis.

Main Methods:

  • Review of existing literature on hemostatic and thrombotic markers.
  • Analysis of studies investigating fibrinolytic parameters, including tissue-type plasminogen activator antigen.
  • Examination of inflammatory markers, particularly C-reactive protein, in relation to cardiovascular events.

Main Results:

  • Abnormal fibrinolytic parameters, especially tissue-type plasminogen activator antigen, are associated with future cardiovascular events.
  • Elevated C-reactive protein levels predict myocardial infarction and stroke risk in both healthy individuals and those with coronary artery disease.
  • Low-grade chronic inflammation is implicated in the process of atherogenesis.

Conclusions:

  • Novel hemostatic and inflammatory markers provide enhanced prediction of arterial thrombotic disease risk.
  • These markers may refine thrombosis research and guide future cardiovascular disease prevention strategies.
  • Further clinical trials are needed to confirm the benefit of modifying these novel risk factors.

More Related Videos

Ferric Chloride-induced Murine Thrombosis Models10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis08:50

Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis

Published on: January 9, 2026

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...